ArticleNeuropsychiatric disease and treatment2026
Modifying Neuropsychiatric and Motor Trajectories in Huntington's Disease Through an Integrated Neurobehavioral Clinic Model.
Article in Neuropsychiatric disease and treatment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Huntington's disease (HD) is a progressive neurodegenerative disorder characterized by worsening motor dysfunction, cognitive decline, and psychiatric symptoms. Psychiatric symptoms in HD arise from progressive frontostriatal circuit dysfunction and often precede motor manifestations, contributing significantly to disability and functional decline. In the absence of disease-modifying therapies, clinical care focuses on symptom management and functional preservation. Methods: This was a retrospective pre-post chart review comparing longitudinal clinical outcomes before and after implementation of a multidisciplinary clinic model in HD patients (N = 56) using an observational study design. Differences were analyzed using paired-samples Results: Anxiety and depression symptom trajectories showed increased stability after initiation of the multidisciplinary clinic (ds = -0.008 and 0.133, respectively) compared to worsening trajectories prior to initiation (ds = 0.309 and 0.366, respectively). About 64-67% of patients were responders post-clinic relative to only 33-43% pre-clinic. Motor symptom severity significantly decreased following integrated clinic model implementation (d = -0.341), representing deviation from the expected progressive trajectory of manifest HD. Cognitive performance remained stable across follow-up intervals. Discussion: Our findings suggest that multidisciplinary integrated care may favorably influence motor and psychiatric symptom trajectories in HD, supporting the value of a coordinated, team-based approach to managing this complex disorder. While observed effects were not particularly large, in the context of a progressive neurodegenerative condition, modest improvement or even stabilization in symptoms represents a clinically meaningful deviation from the expected course of decline. However, conclusions and generalizability are limited by the modest sample size and retrospective observational design.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.